Emergence of Mobilized Colistin Resistance Gene Mcr-8.2 in Multidrug-Resistant Enterobacter Cloacae Isolated from a Patient in China

Siheng Wang,Xiaoyang Ju,Ning Dong,Ruichao Li,Yan Li,Rong Zhang,Yonglu Huang,Hongwei Zhou
DOI: https://doi.org/10.1128/spectrum.01217-22
IF: 3.7
2022-01-01
Microbiology Spectrum
Abstract:Colistin is considered one of the last-resort antibiotics for the treatment of multidrug-resistant (MDR) pathogens infections (1). Liu et al. (2) reported the emergence of plasmid-mediated colistin-resistance gene mcr-1 in 2015. To date, 10 mcr variants, mcr-1 to mcr-10, have been described. mcr-8 was first identified in a carbapenem-resistant Klebsiella pneumoniae isolate (3). Unlike mcr-1, which is widely distributed in Enterobacteriaceae, mcr-8 has only been detected in K. pneumoniae and two closely related species, Raoultella ornithinolytica and Klebsiella quasipneumoniae (4, 5). In recent years, due to the widespread dissemination of extended-spectrum β-lactamases and carbapenemases, Enterobacter cloacae has become the third most common Enterobacteriaceae leading to nosocomial infections (6). Currently, only mcr-1, mcr-4, mcr-9, and mcr-10 have been detected in E. cloacae, mainly mcr-9. In this study, we report the emergence of mcr-8 in E. cloacae and characterize the MDR E. cloacae clinical isolate phenotypically and genotypically.
What problem does this paper attempt to address?